Search

everythinglearnresearchcommunity

for

Search:↓

Thy-1 protein helps improve blood flow and wound healing in the skin.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Some traditional Chinese medicines may have anti-aging benefits and could help with hair growth, but more research is needed.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Early hormones shape sex-specific differences in rat glands.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Hair lotions with 17 alpha-estradiol can reduce hair loss but won't regrow new hair.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.